PMID- 25459347
OWN - NLM
STAT- MEDLINE
DCOM- 20150720
LR  - 20150112
IS  - 1879-2499 (Electronic)
IS  - 1369-8486 (Linking)
VI  - 48 Pt B
DP  - 2014 Dec
TI  - Managing the future: the Special Virus Leukemia Program and the acceleration of 
      biomedical research.
PG  - 231-49
AB  - After the end of the Second World War, cancer virus research experienced a 
      remarkable revival, culminating in the creation in 1964 of the United States 
      National Cancer Institute's Special Virus Leukemia Program (SVLP), an ambitious 
      program of directed biomedical research to accelerate the development of a 
      leukemia vaccine. Studies of cancer viruses soon became the second most highly 
      funded area of research at the Institute, and by far the most generously funded 
      area of biological research. Remarkably, this vast infrastructure for cancer 
      vaccine production came into being before a human leukemia virus was shown to 
      exist. The origins of the SVLP were rooted in as much as shifts in American 
      society as laboratory science. The revival of cancer virus studies was a function 
      of the success advocates and administrators achieved in associating cancer 
      viruses with campaigns against childhood diseases such as polio and leukemia. To 
      address the urgency borne of this new association, the SVLP's architects sought 
      to lessen the power of peer review in favor of centralized Cold War management 
      methods, fashioning viruses as "administrative objects" in order to accelerate 
      the tempo of biomedical research and discovery.
FAU - Scheffler, Robin Wolfe
AU  - Scheffler RW
AD  - American Academy of Arts and Sciences, 136 Irving Street, Cambridge, MA 02138, 
      USA. rscheffler@amacad.org
LA  - eng
PT  - Historical Article
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20141024
PL  - England
TA  - Stud Hist Philos Biol Biomed Sci
JT  - Studies in history and philosophy of biological and biomedical sciences
JID - 9810965
RN  - 0 (Cancer Vaccines)
SB  - IM
MH  - Academies and Institutes/*history
MH  - Biomedical Research/*history
MH  - Cancer Vaccines/*history
MH  - Child
MH  - Healthcare Financing
MH  - History, 20th Century
MH  - Humans
MH  - Leukemia/*history/virology
MH  - Peer Review
MH  - Science/*history
MH  - United States
MH  - Virology/*history
EDAT- 2014/12/03 06:00
MHDA- 2015/07/21 06:00
CRDT- 2014/12/03 06:00
PHST- 2014/09/19 00:00 [received]
PHST- 2014/09/23 00:00 [accepted]
PHST- 2014/12/03 06:00 [entrez]
PHST- 2014/12/03 06:00 [pubmed]
PHST- 2015/07/21 06:00 [medline]
AID - S1369-8486(14)00140-X [pii]
AID - 10.1016/j.shpsc.2014.09.005 [doi]
PST - ppublish
SO  - Stud Hist Philos Biol Biomed Sci. 2014 Dec;48 Pt B:231-49. doi: 
      10.1016/j.shpsc.2014.09.005. Epub 2014 Oct 24.